nonafact
sanquin plasma products b.v. - človeški koagulacijski faktor ix - hemofilija b - antihemoragije - zdravljenje in profilaksa krvavitve pri bolnikih s hemofilijo b (prirojene pomanjkljivosti faktorja ix).
refacto af
pfizer europe ma eeig - moroktokog alfa - hemofilija a - antihemoragije - zdravljenje in preventivo za krvavitev pri bolnikih s hemofilija a (prirojeno faktor viii pomanjkljivost). refacto af je primerno za uporabo pri odraslih in otrocih vseh starosti, vključno z dojenčki. refacto af ne vsebuje von-willebrand dejavnik, in zato ni prikazana v von-willebrand je bolezen.
afstyla
csl behring gmbh - lonoktokog alfa - hemofilija a - antihemoragije - zdravljenje in profilaksa krvavitve pri bolnikih s hemofilijo a (prirojeno pomanjkanje faktorja viii). afstyla se lahko uporablja za vse starostne skupine.
sporimune
le vet beheer -
tigeciklin sandoz 50 mg prašek za raztopino za infundiranje
sandoz d.d. - tigeciklin - prašek za raztopino za infundiranje - tigeciklin 50 mg / 1 viala - tigeciklin
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastiki - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
cyclavance peroral sol-dcp
virbac -
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - predkroglomerna limfoblastna levkemija limfoma - antineoplastična sredstva - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
reopro 2 mg/ml raztopina za injiciranje ali infundiranje
janssen biologics b.v. - abciksimab - raztopina za injiciranje/infundiranje - abciksimab 2 mg / 1 ml - abciksimab
beriplast p combi-set 3 ml prašek in vehikel za lepilo za tkiva
kemofarmacija d.d. - kalcijev klorid dihidrat; trombin, humani - prašek in vehikel za lepilo za tkiva - kalcijev klorid dihidrat 17,7 i.e. / 1 ml trombin, humani1500 i.e. / 1 ml; trombin, humani 1500 i.e. / 1 ml - kombinacije